Eagle Genomics: Funding, Investors & Team (Oct 2026)
Eagle Genomics is a company specializing in enterprise software solutions. Their products are designed to help manage, coordinate, and exploit genomics and other life sciences data. They assist Life Science companies in optimizing the value of their research and development data, and are pioneers in creating the necessary information infrastructure for the genomics era. Their range of software products significantly decreases costs and time needed to complete research, leading to substantial improvements in productivity. By redefining the current industry paradigm, their architecture transforms data sets into valuable data assets, enabling objective measurement of the worth of digital resources and providing clarity on the "return on information." Their team's extensive expertise in biology, bioinformatics, data science, and enterprise-class software engineering sets them apart in the field. Over the past decade, they have successfully addressed various challenges faced by their customers in areas including drug development, personal hygiene, and plant breeding. With a global customer base in the pharmaceuticals, fast moving consumer goods, and agri-tech industries, they deeply understand the common issues these sectors face in managing ever-growing amounts of data and information resources. Eagle Genomics is at the forefront of tackling the challenges, risks, and opportunities involved in creating and delivering the enterprise information architecture needed for the genomics era.
Eagle Genomics has raised $3.6M across 1 funding round on record, the most recent an undisclosed round of $3.6M announced in Sep 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eagle Genomics Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Eagle Genomics Funding Rounds
Eagle Genomics Founders and Leadership Team
No contact details are on record for this team yet.
Eagle Genomics Funding Compared to Other Biotechnology Startups
Eagle Genomics' latest round of $3.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eagle Genomics in Biotechnology and Cambridge
Companies Similar to Eagle Genomics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Eagle Genomics Funding FAQs
What does Eagle Genomics do?
Eagle Genomics is a company specializing in enterprise software solutions. Their products are designed to help manage, coordinate, and exploit genomics and other life sciences data. They assist Life Science companies in optimizing the value of their research and development data, and are pioneers in creating the necessary information infrastructure for the genomics era. Their range of software products significantly decreases costs and time needed to complete research, leading to substantial improvements in productivity. By redefining the current industry paradigm, their architecture transforms data sets into valuable data assets, enabling objective measurement of the worth of digital resources and providing clarity on the "return on information." Their team's extensive expertise in biology, bioinformatics, data science, and enterprise-class software engineering sets them apart in the field. Over the past decade, they have successfully addressed various challenges faced by their customers in areas including drug development, personal hygiene, and plant breeding. With a global customer base in the pharmaceuticals, fast moving consumer goods, and agri-tech industries, they deeply understand the common issues these sectors face in managing ever-growing amounts of data and information resources. Eagle Genomics is at the forefront of tackling the challenges, risks, and opportunities involved in creating and delivering the enterprise information architecture needed for the genomics era.
How much funding has Eagle Genomics raised?
Eagle Genomics has raised $3.6M across 1 round on record. The most recent is an undisclosed round of $3.6M announced in Sep 2023.
When did Eagle Genomics last raise funding?
Eagle Genomics' most recent funding round on record is an undisclosed round of $3.6M, announced in Sep 2023.
Who founded Eagle Genomics?
FundedIQ lists Abel Ureta Vidal (Founder) at Eagle Genomics.
Where is Eagle Genomics headquartered?
Eagle Genomics is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Eagle Genomics have?
Eagle Genomics is in the 101-250 employee band.
How does Eagle Genomics' funding compare to other Biotechnology startups?
Eagle Genomics' latest round of $3.6M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Eagle Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eagle Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.